Cargando…

Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia

Detalles Bibliográficos
Autores principales: Li, Quanfu, Jin, Gaowa, Jiang, Caihong, Zhang, Zewei, Hou, Jixiang, Zhao, Juan, Chen, Feng, Li, Zhenhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425230/
https://www.ncbi.nlm.nih.gov/pubmed/34522277
http://dx.doi.org/10.5114/aoms/141134
_version_ 1783749816614912000
author Li, Quanfu
Jin, Gaowa
Jiang, Caihong
Zhang, Zewei
Hou, Jixiang
Zhao, Juan
Chen, Feng
Li, Zhenhao
author_facet Li, Quanfu
Jin, Gaowa
Jiang, Caihong
Zhang, Zewei
Hou, Jixiang
Zhao, Juan
Chen, Feng
Li, Zhenhao
author_sort Li, Quanfu
collection PubMed
description
format Online
Article
Text
id pubmed-8425230
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-84252302021-09-13 Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia Li, Quanfu Jin, Gaowa Jiang, Caihong Zhang, Zewei Hou, Jixiang Zhao, Juan Chen, Feng Li, Zhenhao Arch Med Sci Letter to the Editor Termedia Publishing House 2021-08-09 /pmc/articles/PMC8425230/ /pubmed/34522277 http://dx.doi.org/10.5114/aoms/141134 Text en Copyright: © 2021 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Letter to the Editor
Li, Quanfu
Jin, Gaowa
Jiang, Caihong
Zhang, Zewei
Hou, Jixiang
Zhao, Juan
Chen, Feng
Li, Zhenhao
Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia
title Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia
title_full Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia
title_fullStr Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia
title_full_unstemmed Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia
title_short Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia
title_sort prophylactic administration of recombinant human thrombopoietin attenuates xelox or sox regimen-induced thrombocytopaenia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425230/
https://www.ncbi.nlm.nih.gov/pubmed/34522277
http://dx.doi.org/10.5114/aoms/141134
work_keys_str_mv AT liquanfu prophylacticadministrationofrecombinanthumanthrombopoietinattenuatesxeloxorsoxregimeninducedthrombocytopaenia
AT jingaowa prophylacticadministrationofrecombinanthumanthrombopoietinattenuatesxeloxorsoxregimeninducedthrombocytopaenia
AT jiangcaihong prophylacticadministrationofrecombinanthumanthrombopoietinattenuatesxeloxorsoxregimeninducedthrombocytopaenia
AT zhangzewei prophylacticadministrationofrecombinanthumanthrombopoietinattenuatesxeloxorsoxregimeninducedthrombocytopaenia
AT houjixiang prophylacticadministrationofrecombinanthumanthrombopoietinattenuatesxeloxorsoxregimeninducedthrombocytopaenia
AT zhaojuan prophylacticadministrationofrecombinanthumanthrombopoietinattenuatesxeloxorsoxregimeninducedthrombocytopaenia
AT chenfeng prophylacticadministrationofrecombinanthumanthrombopoietinattenuatesxeloxorsoxregimeninducedthrombocytopaenia
AT lizhenhao prophylacticadministrationofrecombinanthumanthrombopoietinattenuatesxeloxorsoxregimeninducedthrombocytopaenia